ActivSight

By Activ Surgical
· United States
Add-on laparoscopic imaging module that overlays dye-free blood flow maps (laser speckle) and ICG fluorescence on the surgical video, as a real-time aid for surgeons in minimally invasive surgery.
Diagnostic
Surgery
Production
CE Marked FDA Cleared
Regulatory status
CE Marked FDA Cleared
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
United States
AI type
Diagnostic

Precise indication

Intraoperative augmented imaging for surgery.

Regulatory status

FDA: 510(k) K203550, Class II, April 2021; K231344, August 2023, sterilisation change only (confirmed).
CE: CE mark under MDR announced December 2022; class and notified body not public (vendor-claimed).
AI function: no separate FDA clearance found for the ‘colorectal AI mode’ (confirmed: FDA database checked, November 2026).

Clinical evidence

Vendor-supported

Liu et al., Surg Endosc 2023 (n=67, vendor-funded): perfusion seen in 97.5-100% of robotic and laparoscopic cases, no adverse events.
Skinner et al., Dis Colon Rectum 2024 (n=40, vendor-funded): imaging changed the surgical decision in 17.5% of left-sided colorectal resections.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

The vendor claims over 2,000 surgical cases and availability in 17+ countries, without a public list of sites. The first case with the AI mode was done at Ohio State University Wexner Medical Center (US) in December 2022.

Interoperability

Fits between existing laparoscope and camera; overlays on standard monitors; no DICOM/HL7/FHIR details found (vendor-claimed).

European status

Editorial verdict

Limits and uncertainties

– The cleared indication covers imaging only; the regulatory status of the AI features is unclear.
– Evidence is small and mostly vendor-funded feasibility work; no independent ActivSight study found.
– No data yet showing fewer anastomotic leaks or better patient outcomes.
– Not for stand-alone bile duct imaging; use with white light and cholangiography when indicated.
– Adoption figures are vendor-declared; no named European site in routine use.

Sources

https://www.businesswire.com/news/home/20230109005508/en/Activ-Surgical-Announces-Completion-of-First-AI-Enabled-Case-Using-Its-ActivSight-Intelligent-Light Regulator — FDA 510(k) K203550, ActivSight Intraoperative Imaging System (Innolitics mirror of FDA record), April 2021 https://fda.innolitics.com/device/K203550 Press release (vendor) — Activ Surgical, ActivSight secures CE Mark approval, BioSpace/Business Wire, December 2022 https://www.biospace.com/activ-surgical-secures-ce-mark-approval-for-activsight-intelligent-light News — The Robot Report, Activ Surgical completes first case with ActivSight AI mode, January 2023 https://www.therobotreport.com/activ-surgical-completes-first-case-with-activsight/ Website (vendor) — Activ Surgical, ActivSight home page (cases, countries), 2026
Homepage
Study (vendor-funded) — Liu YZ et al., LSCI utility and usability in robotic and laparoscopic surgery, Surgical Endoscopy, 2023 https://pmc.ncbi.nlm.nih.gov/articles/PMC9483347/ Regulator — FDA 510(k) K231344, ActivSight Intraoperative Imaging System (Innolitics mirror of FDA record), August 2023 https://fda.innolitics.com/device/K231344 Regulator — FDA, K231344 clearance letter and 510(k) summary, accessdata.fda.gov, August 2023 https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231344.pdf Study (vendor-funded) — Skinner GC et al., Clinical utility of LSCI in left-sided colorectal resections, Diseases of the Colon & Rectum, 2024 https://doi.org/10.1097/dcr.0000000000003098

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Activ Surgical
Headquarters
United States
AI type
Diagnostic
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.